Abbrea Capital, LLC Bristol Myers Squibb CO Transaction History

Abbrea Capital, LLC

$755 Million
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$47.98 - $54.4 $28,740 - $32,585	-599 Reduced 10.25%	5,245 $284,000
Q4 2023 Feb 02, 2024	SELL	$48.48 - $57.85 $257,913 - $307,762	-5,320 Reduced 47.65%	5,844 $300,000
Q3 2023 Oct 31, 2023	BUY	$57.89 - $64.73 $9,551 - $10,680	165 Added 1.5%	11,164 $648,000
Q2 2023 Aug 01, 2023	BUY	$63.71 - $70.74 $62,053 - $68,900	974 Added 9.72%	10,999 $703,000
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $9,856 - $11,179	150 Added 1.52%	10,025 $695,000
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $56,496 - $66,899	825 Added 9.12%	9,875 $710,000
Q3 2022 Nov 03, 2022	SELL	$0.13 - $76.84 $32 - $19,363	-252 Reduced 2.71%	9,050 $643,000
Q2 2022 Aug 02, 2022	SELL	$72.62 - $79.98 $7,262 - $7,998	-100 Reduced 1.06%	9,302 $721,000
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $15,677 - $18,798	255 Added 2.79%	9,402 $692,000
Q4 2021 Feb 04, 2022	SELL	$53.63 - $62.52 $3,217 - $3,751	-60 Reduced 0.65%	9,147 $570,000
Q3 2021 Nov 04, 2021	SELL	$59.17 - $69.31 $77,808 - $91,142	-1,315 Reduced 12.5%	9,207 $549,000
Q2 2021 Aug 04, 2021	BUY	$61.91 - $67.42 $83,764 - $91,219	1,353 Added 14.76%	10,522 $703,000
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $58,153 - $65,405	980 Added 11.97%	9,169 $583,000
Q4 2020 Jan 21, 2021	BUY	$57.74 - $65.43 $24,308 - $27,546	421 Added 5.42%	8,189 $512,000
Q3 2020 Oct 20, 2020	BUY	$57.43 - $63.64 $51,227 - $56,766	892 Added 12.97%	7,768 $468,000
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $15,568 - $18,201	284 Added 4.31%	6,876 $404,000
Q1 2020 Apr 29, 2020	BUY	$46.4 - $67.43 $22,875 - $33,242	493 Added 8.08%	6,592 $367,000
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $300,131 - $391,494	6,099 New	6,099 $392,000
Q4 2018 Feb 05, 2019	SELL	$48.76 - $63.23 $231,024 - $299,583	-4,738 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$55.19 - $62.25 $25,497 - $28,759	462 Added 10.8%	4,738 $294,000
Q2 2018 Aug 08, 2018	BUY	$50.53 - $62.98 $606 - $755	12 Added 0.28%	4,276 $237,000
Q1 2018 May 10, 2018	BUY	$59.92 - $68.98 $8,688 - $10,002	145 Added 3.52%	4,264 $270,000
Q4 2017 Feb 01, 2018	BUY	$59.94 - $65.35 $21,338 - $23,264	356 Added 9.46%	4,119 $252,000
Q3 2017 Nov 07, 2017	BUY	$55.23 - $63.74 $207,830 - $239,853	3,763	3,763 $240,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.2 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.4 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.51 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.62 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.62 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abbrea Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abbrea Capital, LLC with notifications on news.

Account